Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

Paraiso, Kim H. T.; Das Thakur, Meghna; Fang, Bin; Koomen, John M.; Fedorenko, Inna V.; John, Jobin K.; Tsao, Hensin; Flaherty, Keith T.; Sondak, Vernon K.; Messina, Jane L.; Pasquale, Elena B.; Villagra, Alejandro; Rao, Uma N.; Kirkwood, John M.; Meier, Friedegund; Sloot, Sarah; Gibney, Geoffrey T.; Stuart, Darrin; Tawbi, Hussein; Smalley, Keiran S. M.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

Author:

Paraiso, Kim H. T.; Das Thakur, Meghna; Fang, Bin; Koomen, John M.; Fedorenko, Inna V.; John, Jobin K.; Tsao, Hensin; Flaherty, Keith T.; Sondak, Vernon K.; Messina, Jane L.; Pasquale, Elena B.; Villagra, Alejandro; Rao, Uma N.; Kirkwood, John M.; Meier, Friedegund; Sloot, Sarah; Gibney, Geoffrey T.; Stuart, Darrin; Tawbi, Hussein; Smalley, Keiran S. M.

Tübinger Autor(en):

Meier, Friedegund

Published in:

Cancer Discovery (2015), Bd. 5, H. 3, S. 264-273

Verlagsangabe:

Amer Assoc Cancer Research

Language:

English

Full text:

http://dx.doi.org/10.1158/2159-8290.CD-14-0293

ISSN:

2159-8274